Publication Date:
2015
Abstract:
Febuxostat has been recently introduced in the market as an alternative urate-lowering drug. Its allergenic profile has not been fully outlined and the clinical management of hypersensitivity reactions is not standardized. We report 2 cases of hypersensitivity reactions to febuxostat and present a desensitization protocol.
CRIS type:
1.1 Articolo in rivista
Keywords:
Febuxostat hypersensitivity; desensitization
List of contributors:
Di Paolo, C; Minetti, S; Mineni, M; Inverardi, S; Rizzini, Fl; Cinquini, M; Tosoni, C.
Published in: